Eiger BioPharmaceuticals, Inc. EIGR
1.73 0.00 (+0.00%)
At closeJun 17, 2025, 4:00 PM EDT
1.73 Day range 1.90
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2022 · select a line to chart its full history
Income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 13.48M | 12.14M | 0 | 0 | 0 | |
| 11.65M | 11.40M | 0 | 0 | 0 | |
| -92.74M | -76.94M | -62.15M | -68.90M | -51.05M | |
| -96.78M | -33.92M | -65.05M | -70.25M | -52.39M | |
| -69.60 | -30.00 | -69.30 | -92.40 | -115.20 |
Balance sheet
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 25.80M | 22.22M | 28.86M | 39.37M | 61.26M | |
| 120.14M | 126.40M | 143.59M | 105.14M | 102.45M | |
| 64.83M | 54.00M | 48.56M | 48.66M | 35.86M | |
| 40.20M | 32.54M | 32.51M | 32.24M | 25.62M | |
| 55.31M | 72.40M | 95.03M | 56.48M | 66.59M |
Cash flow
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| -83.01M | -71.34M | -63.19M | -63.61M | -42.67M | |
| 9.63M | 61.53M | -44.79M | -16.47M | -29.09M | |
| 76.95M | 3.17M | 97.46M | 58.20M | 100.98M | |
| -340.00K | 56.00K | -258.00K | -475.00K | -142.00K | |
| 3.58M | -6.64M | -10.51M | -21.89M | 29.23M |